Edaravone alleviates Alzheimer's disease-type pathologies and cognitive deficits - Wikidata - wikimedia - TriplyDB

Edaravone alleviates Alzheimer's disease-type pathologies and cognitive deficits

Edaravone alleviates Alzheimer's disease-type pathologies and cognitive deficits

http://www.wikidata.org/entity/Q35549137

about

Targeting neuroinflammation in Alzheimer's disease A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials APC/CCdh1-Rock2 pathway controls dendritic integrity and memory.Dimeric bis (heptyl)-Cognitin Blocks Alzheimer's β-Amyloid Neurotoxicity Via the Inhibition of Aβ Fibrils Formation and Disaggregation of Preformed Fibrils.Protective effect of Edaravone against hypoxia-induced cytotoxicity in osteoblasts MC3T3-E1 cells.Protective Effects of Edaravone in Adult Rats with Surgery and Lipopolysaccharide Administration-Induced Cognitive Function Impairment.Rationally Designed CeNP@MnMoS4 Core-Shell Nanoparticles for Modulating Multiple Facets of Alzheimer's Disease.Perspectives on the Tertiary Prevention Strategy for Alzheimer's Disease.Kiwifruit Alleviates Learning and Memory Deficits Induced by Pb through Antioxidation and Inhibition of Microglia Activation In Vitro and In Vivo.Neurovascular Specifications in the Alzheimer-Like Brain of Mice Affected by Focal Cerebral Ischemia: Implications for Future Therapies.Inhibition of amyloid oligomerization into different supramolecular architectures by small molecules: mechanistic insights and design rules.Lipid-based nanosystem of edaravone: development, optimization, characterization and in vitro/in vivo evaluation.Translational Assays for Assessment of Cognition in Rodent Models of Alzheimer's Disease and Dementia.Edaravone injection reverses learning and memory deficits in a rat model of vascular dementia.Molecular Mechanisms behind Free Radical Scavengers Function against Oxidative Stress.Loss of tau rescues inflammation-mediated neurodegeneration.Analogues of desferrioxamine B designed to attenuate iron-mediated neurodegeneration: synthesis, characterisation and activity in the MPTP-mouse model of Parkinson's disease.Neuroprotective effects of liquiritin on cognitive deficits induced by soluble amyloid-β1-42 oligomers injected into the hippocampus.Alzheimer’s Disease, Brain Injury, and C.N.S. Nanotherapy in Humans: Sonoporation Augmenting Drug Targeting.Cerebrospinal Fluid Amyloid-β Levels are Increased in Patients with Insomnia.Peritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP/PS1 mouse model.Resveratrol Intervenes Cholesterol- and Isoprenoid-Mediated Amyloidogenic Processing of AβPP in Familial Alzheimer's Disease.Self-nanomicellizing solid dispersion of edaravone: part I – oral bioavailability improvement.Curcumin-loaded PLGA-PEG nanoparticles conjugated with B6 peptide for potential use in Alzheimer's disease

P2860

Q28078474-AFBCF18C-5B67-4009-9130-9043D0E84285 Q30844551-C4A195A7-ED4E-4CD7-9516-B3E2AA026AE9 Q33620199-4DC29F97-32C4-44E8-8B37-67B17F9ABBF0 Q35823517-986B6380-6420-4444-ADBB-350F542427E1 Q35848920-AE1ADF07-6812-4015-BFFF-FACDC6D4F799 Q35999736-75FF51BA-C4B2-4534-9D88-DC4929E14178 Q36094624-E2767159-B139-41F3-9DBB-52BE0383B411 Q37204006-3025283C-A3E5-41C5-BDAE-12AD43801CF1 Q37721037-1B913DF0-96D8-46A4-9F8D-D068BD0D7B46 Q38663632-1D8AD993-9BF4-436B-B8FA-3DA39DD9327B Q38686092-D18E740E-5135-40F7-BC0D-F7EBB4801E1F Q38699643-1B5B32EC-ACEC-4E51-BE61-38275754A9A4 Q38956724-F7042C0D-535B-439C-95CF-4E52F1F7B700 Q39173214-FF9A5F20-9E6A-45A3-9306-ECA2C9ADEDAB Q39429504-B8D7018B-ADEE-4237-B072-D3C35E1891F8 Q41590526-EE1B49E7-3718-40E7-98E2-E2008FDDA116 Q46372704-E25882D4-33A5-4E01-B0DD-ED7305923428 Q46494206-319DA2E4-6490-4071-8235-905BBA822A09 Q47408666-06510C3E-E59A-42C7-9156-BDCAC9EA8E2A Q47650733-3E1A45FB-66F5-46B8-B6A4-3C4A0FD311F3 Q48183350-56BB180A-07CC-4D8D-A230-1A91D6807EC2 Q51212850-CD12F14C-EAC3-4FD8-843F-59D352AB942E Q55686117-238916DE-99DB-4415-A2D8-218EFAE054AF Q58776704-C2B18F84-ED09-46FB-866E-FDEA287E3964

P2860

Edaravone alleviates Alzheimer's disease-type pathologies and cognitive deficits

http://www.wikidata.org/entity/Q35549137

description

2015 nî lūn-bûn

@nan

2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Edaravone alleviates Alzheimer's disease-type pathologies and cognitive deficits

@ast

Edaravone alleviates Alzheimer's disease-type pathologies and cognitive deficits

@en

type

label

Edaravone alleviates Alzheimer's disease-type pathologies and cognitive deficits

@ast

Edaravone alleviates Alzheimer's disease-type pathologies and cognitive deficits

@en

prefLabel

Edaravone alleviates Alzheimer's disease-type pathologies and cognitive deficits

@ast

Edaravone alleviates Alzheimer's disease-type pathologies and cognitive deficits

@en

P1433

Q35549137-93760955-5B8F-4AF1-9AF5-D19B6CE8B1AC

P1476

Q35549137-7E075FBB-A6BA-47F6-995E-5BD5FD768BAC

P2093

Q35549137-1D039DEA-F9D7-4B09-A050-2A10A999D33C

Q35549137-3A9DAFF6-8455-4D10-A62D-891D27EF7C73

Q35549137-459EBBA2-8463-4D89-8FE5-7E9FCF03F050

Q35549137-4CE589A7-1F61-495D-B36A-20065AFB7746

Q35549137-4EFCF67C-41BC-471C-8C2E-69F78C1FA15E

Q35549137-50823B80-8FB2-420E-95D0-93E8AB3C65ED

Q35549137-55AE2A62-591D-4909-9294-7E319DAEA61B

Q35549137-5BFE0A7A-7718-494D-89E4-58499FBE73C9

Q35549137-64044C48-577B-4D95-91BF-48F57C33C2E9

Q35549137-8EBEC94F-76FC-4629-8076-044BF55CE5CA

P2860

Q35549137-0580E7FF-1684-4D0F-85DA-06FA3B955B1A

Q35549137-0C88A27F-2FA6-42C6-96E9-87FCF7D95495

Q35549137-148659DD-66E5-4601-80CF-C4B083A91545

Q35549137-155F8A52-B005-440C-9D96-A7C47F9F0845

Q35549137-1957AA66-CCEF-45EB-8237-4233792969AB

Q35549137-21984C95-1FAF-41B3-BF17-54D6687457EC

Q35549137-23BC1D99-E064-4F4C-BA0C-C6127A143652

Q35549137-2435960E-EFDC-463F-BCDD-92B9EA68D6D6

Q35549137-26D84600-52AF-44A5-8BAD-B9D0193B903F

Q35549137-2896E480-0EC6-4163-9219-0F4D8B61A62F

P304

Q35549137-0D52F382-CBFD-4D20-9C4C-AFE189AF0DDD

P31

Q35549137-9DC58657-A7C4-4B43-A692-1A6107358C6D

P356

Q35549137-CC572F0A-F3A6-48D3-AE3D-8926A49EA6BA

P407

Q35549137-C8C3CD41-0B8D-480B-BB87-DBD9BA521764

P433

Q35549137-F43A03CA-8F93-49B7-A85F-5FC7809E1606

P478

Q35549137-DD1B2EC7-1C0F-487E-A2B0-EEF017540041

P50

Q35549137-AEE20BBC-BABE-400F-8D98-347B674123E3

Q35549137-E2911F5C-B18A-4CF2-B7B5-87BB7AEC43F8

Q35549137-F853F314-1841-45E9-8567-4A6C65758FFE

P577

Q35549137-16299271-5447-4C3F-98E7-D3321A5ED250

P5875

Q35549137-C528A2CC-5DD8-4B73-93CA-957DF9EA4DA6

P698

Q35549137-159E518A-8E49-415D-8ADE-1E35A4D3A190

P921

Q35549137-2EEC817E-98F1-44A7-BD17-AA189C51F0A6

Q35549137-DFA87733-3A67-4521-BD64-960BCFA53B7D

P932

Q35549137-57F28751-AD18-4BEE-8E30-C5C38157CEA5

P356

PNAS.1422998112

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Edaravone alleviates Alzheimer's disease-type pathologies and cognitive deficits

@en

P2093

Ankit Parikh

http://www.w3.org/2001/XMLSchema#string

Cheng-Hui Liu

http://www.w3.org/2001/XMLSchema#string

Chi Zhu

http://www.w3.org/2001/XMLSchema#string

Chun-Rong Liang

http://www.w3.org/2001/XMLSchema#string

Fan Zeng

http://www.w3.org/2001/XMLSchema#string

Gui-Hua Zeng

http://www.w3.org/2001/XMLSchema#string

Hai-Wei Xu

http://www.w3.org/2001/XMLSchema#string

Hua-Dong Zhou

http://www.w3.org/2001/XMLSchema#string

Jia Chen

http://www.w3.org/2001/XMLSchema#string

Jia Liu

http://www.w3.org/2001/XMLSchema#string

P2860

The state of US health, 1990-2010: burden of diseases, injuries, and risk factors

Edaravone for acute ischaemic stroke

γ-Secretase inhibitors and modulators.

Molecular basis for amyloid- polymorphism

Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine.

Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo

Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.

Grape-derived polyphenolics prevent Abeta oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease.

Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes.

Contribution of reactive oxygen species to cerebral amyloid angiopathy, vasomotor dysfunction, and microhemorrhage in aged Tg2576 mice.

P304

5225-5230

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1422998112

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275222112

http://www.w3.org/2001/XMLSchema#string

P698

25847999

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4413288

http://www.w3.org/2001/XMLSchema#string